IIT Guwahati Alumni Led Startup Develop Device for Diagnosis of Chronic Non-Communicable Diseases

Content Curator

IITG alumni-led startup Primary Healthtech Private Limited has developed an indigenous point-of-care-testing (POCT) device that will enable testing at patients’ sites at a low cost to enable early screening as well as long-term disease management.

IIT Guwahati Alumni Led Startup Develop Device for Diagnosis of Chronic Non-Communicable Diseases

New Delhi: Primary Healthtech Private Limited, a startup led by alumni of the Indian Institute of Technology Guwahati (IITG) has developed an indigenous Point-Of-Care-Testing (POCT) which will diagnose chronic non-communicable diseases

The device titled MobilabTM developed by students of IIT Guwahati will test about 25 parameters in blood to diagnose early chronic diseases related to kidney, liver, heart, and pancreas malfunctions. It will function through an IoT-enabled Android app.

IIT Guwahati Courses	IIT Guwahati Placement	IIT Guwahati Admissions

Informing about this initiative, Primary Healthtech Chief Executive Officer Sahil Jagnani shared that MobilabTM will be able to perform 150 tests with a single charge of the battery, offering it a digitally connected ecosystem so that it can be used in remotest locations.

According to the World Health Organization's (WHO) most recent reports, Non-Communicable Diseases (NCDs) are responsible for almost 41 million (74%) of deaths worldwide. With the help of this device, early screening for Non-Communicable Diseases (NCDs) will be possible.

Sahil Jagnani said, ''The vision of MobilabTM is to make diagnosis available to fellow citizens at an affordable cost, along with generating instant results to speed up the early screening, disease management, and treatment''.

MobilabTM will make testing affordable at patients’ sites, enabling both early detection and long-term disease management. It produces data, a digital report, and a patient's electronic health record in 10 minutes that can be quickly shared with medical professionals.

For this device, a total of 11 parameters have so far been validated in NABL-accredited and government labs, including the heart profile's cholesterol, LDL, HDL, and triglycerides, liver profile's total bilirubin, albumin, and total protein, kidney profile's creatinine, glucose, and uric acid, and haematology profile's haemoglobin and diabetic in glucose.

MobilabTM will be used at various levels in hospitals such as Guwahati Medical College & Hospital, Guwahati Neurological Research Centre, Nemcare, Army Hospital, AIIMS New Delhi, as well as various parts of Assam, Maharashtra, Uttar Pradesh, Madhya Pradesh, Gujrat, Delhi, and Arunachal Pradesh.

Also Read: